Market Cap 47.82B
Revenue (ttm) 30.24B
Net Income (ttm) 712.32M
EPS (ttm) N/A
PE Ratio 9.37
Forward PE 8.65
Profit Margin 2.36%
Debt to Equity Ratio 0.65
Volume 1,105,900
Avg Vol 2,252,010
Day's Range N/A - N/A
Shares Out 3.18B
Stochastic %K 100%
Beta 0.26
Analysts Strong Sell
Price Target $16.67

Latest News on TAK

Takeda-backed Ascentage Pharma aims to raise $126 mln in US IPO

Jan 23, 2025, 7:14 PM EST - 4 months ago

Takeda-backed Ascentage Pharma aims to raise $126 mln in US IPO


Takeda Announces New Assignments of Directors

Jun 26, 2024, 3:05 AM EDT - 1 year ago

Takeda Announces New Assignments of Directors